ChiCTR-TRC-12002641已完成Unknown
Percutaneous pulmonary arterial denervation for treament of chronic heart failure with secondary pulmonary hypertension
NMHB-20121881 个研究点 分布在 1 个国家开始时间: 2012年10月31日最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 发起方
- 试验地点
- 1
研究概览
简要总结
Pulmonary hypertension(PH) predicts the worse outcome in patients with chronic heat failure. Medications have been tested in the setting of PH. Previous studies reported the improved exercise ability without reduction of hemodynamics. Pulmonary arterial denervation has never been studied in these patients subset
研究设计
- 研究类型
- Interventional
- 主要目的
- 随机平行对照
入排标准
- 年龄范围
- 18 至 75（—）
- 性别
- Male
入选标准
- •Chronic heart failure (ischemic or non-ischemic);
- •Secondary PH defined as mean pulmonary arterial pressure (MPAP)>25 mm Hg at rest;
- •NYHA II-IV;
- •Left ventricular eject fraction<=40%.
排除标准
- •Idiopathic PAH;
- •Interstial Lung disease;
- •Connective tissue disease;
- •Chronic thromboembolic PH;
- •Portal hypertension;
- •non-left side heart failure.
研究者
研究点 (1)
Loading locations...
相似试验
招募中
4 期
A randomized, double-blind, placebo-controlled, multicentre trial, assessing the impact of ferric carboxymaltose on exercise capacity and functional status in pulmonary hypertension (IRON-PH)Pulmonary hypertension2025-522936-14-00Ziekenhuis Oost Limburg306
尚未招募
不适用
Pulmonary Artery Denervation for Heart Failure With Preserved Left Ventricular Ejection FractionNCT07331220Nanjing First Hospital, Nanjing Medical University310
招募中
4 期
The Impact of IV Iron on Exercise Capacity and Quality of Life in Pulmonary HypertensionPulmonary HypertensionNCT07359599Ziekenhuis Oost-Limburg306
尚未招募
不适用
Patient-Reported Outcomes and Adherence After Transition From Inhaled Iloprost to Oral Selexipag in Pulmonary Arterial HypertensionNCT07356375University of Sao Paulo General Hospital32
招募中
不适用
AIRDROP: Can we Improve Adherence to Inhaled Treatment for Pulmonary Arterial Hypertension?NCT07457762University of Sao Paulo General Hospital72